Company Filing History:
1 out of 1,289 
1 out of 13 Years Active: 2019
Title: Marten Szibor: Innovator in Cancer Diagnosis and Therapy
Introduction
Marten Szibor is a notable inventor based in Espoo, Finland. He has made significant contributions to the field of cancer research, particularly in the diagnosis and therapy of lung cancer. His innovative work has the potential to impact medical practices and improve patient outcomes.
Latest Patents
Marten Szibor holds a patent for "Isoforms of GATA6 and NKX2-1 as markers for diagnosis and therapy of cancer and as targets for anti-cancer therapy." This invention relates to a method for assessing whether a subject suffers from cancer or is prone to it, specifically lung cancer. The method involves measuring the amounts of specific isoforms of GATA6 and/or NKX2-1 in a sample from the subject. Additionally, the invention includes a composition for use in medicine that comprises inhibitors of these isoforms, as well as a kit designed for assessing cancer susceptibility.
Career Highlights
Throughout his career, Marten Szibor has worked with esteemed institutions such as the Max Planck Society for the Advancement of Science and Justus Liebig University Giessen. His experience in these organizations has contributed to his expertise in cancer research and innovation.
Collaborations
Marten has collaborated with notable colleagues, including Guillermo Barreto and Aditi Mehta. These partnerships have likely enhanced his research and development efforts in the field of cancer diagnostics and therapy.
Conclusion
Marten Szibor's contributions to cancer research through his innovative patent demonstrate his commitment to improving medical diagnostics and therapies. His work has the potential to significantly influence the future of cancer treatment.